Sertraline Should NOT Be Used as First-Line Treatment for Anorexia Nervosa
Sertraline is not recommended for anorexia nervosa, as eating disorder-focused psychotherapy is the primary treatment, and the 2023 APA guidelines do not support medication as a primary intervention for this condition. 1
Treatment Framework for Anorexia Nervosa
The most recent and authoritative guidance from the American Psychiatric Association (2023) is unequivocal about treatment priorities:
Primary Treatment (Level 1B Evidence)
- Adults: Eating disorder-focused psychotherapy targeting normalization of eating behaviors, weight restoration, and psychological aspects (fear of weight gain, body image disturbance) 1
- Adolescents/Emerging Adults: Family-based treatment with caregiver involvement for eating normalization and weight restoration 1
Why Sertraline Is Not Recommended
The APA guidelines conspicuously omit any medication recommendations for anorexia nervosa, in stark contrast to their explicit endorsement of SSRIs (specifically fluoxetine 60mg daily) for bulimia nervosa 1. This absence is deliberate and clinically significant—it reflects the lack of evidence supporting antidepressant efficacy in anorexia nervosa for improving core eating disorder symptoms or weight restoration.
Critical Safety Considerations
If sertraline is being considered for a co-occurring condition (e.g., comorbid depression or anxiety) in a patient with anorexia nervosa, several safety concerns must be addressed:
Mandatory Pre-Treatment Assessment
Before any SSRI use in restrictive eating disorders, the APA mandates 1:
- ECG monitoring (sertraline can prolong QTc intervals, and patients with anorexia already have cardiac vulnerability from malnutrition)
- Complete metabolic panel including electrolytes
- Vital signs with orthostatic measurements
- Assessment for bradycardia and hypotension
Specific Sertraline Risks in This Population
Hyponatremia risk is particularly concerning 2. Patients with anorexia nervosa who are:
- Volume depleted (common in restrictive eating)
- Taking diuretics (sometimes used for purging)
- Malnourished
...are at substantially elevated risk for SSRI-induced hyponatremia, which can cause confusion, weakness, falls, seizures, and in severe cases, death.
Serotonin syndrome risk increases if the patient is on multiple medications 2, which is relevant given the multidisciplinary treatment approach required for eating disorders.
Clinical Algorithm
- First: Implement eating disorder-focused psychotherapy (individual for adults, family-based for adolescents) 1
- Establish medical stability: Ensure adequate nutrition, normal electrolytes, stable vital signs, normal ECG 1
- Only if treating a distinct comorbid condition (not the eating disorder itself):
- Obtain baseline ECG, electrolytes, vital signs
- Start at lowest dose
- Monitor closely for hyponatremia symptoms
- Reassess frequently for clinical worsening or suicidality 2
Common Pitfall to Avoid
Do not prescribe sertraline thinking it will help with weight restoration or core anorexia symptoms—there is no evidence for this, and psychotherapy is the established treatment with moderate-quality evidence (1B rating) 1. The medication may only be appropriate for managing a separate, diagnosed psychiatric condition after medical stabilization, and even then requires heightened monitoring given the physiological vulnerabilities inherent to anorexia nervosa.